NASDAQ:ASBP - Nasdaq - US7389201077 - Common Stock - Currency: USD
0.225
+0 (+0.45%)
The current stock price of ASBP is 0.225 USD. In the past month the price decreased by -53.81%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 51.87 | 676.41B | ||
JNJ | JOHNSON & JOHNSON | 15.22 | 367.98B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 19.24 | 299.26B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.57 | 222.69B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.93 | 218.30B | ||
MRK | MERCK & CO. INC. | 9.96 | 194.81B | ||
PFE | PFIZER INC | 7.26 | 132.58B | ||
SNY | SANOFI-ADR | 13.57 | 126.50B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.38 | 95.34B | ||
GSK | GSK PLC-SPON ADR | 7.02 | 78.45B | ||
ZTS | ZOETIS INC | 27.01 | 72.38B | ||
HLN | HALEON PLC-ADR | 22.73 | 50.17B |
Aspire Biopharma Holdings, Inc. operates as a biopharmaceutical company that engaged in developing and marketing a disruptive technology for drugs, nutraceuticals & supplements. The company develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. The company has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. The company also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.
ASPIRE BIOPHARMA HOLDINGS IN
194 Candelaro Drive, #233
Humacao NEW YORK PR
Employees: 0
Phone: 15617048527
The current stock price of ASBP is 0.225 USD. The price increased by 0.45% in the last trading session.
The exchange symbol of ASPIRE BIOPHARMA HOLDINGS IN is ASBP and it is listed on the Nasdaq exchange.
ASBP stock is listed on the Nasdaq exchange.
ASPIRE BIOPHARMA HOLDINGS IN (ASBP) has a market capitalization of 11.00M USD. This makes ASBP a Nano Cap stock.
ASPIRE BIOPHARMA HOLDINGS IN (ASBP) currently has 0 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ASBP does not pay a dividend.
ASPIRE BIOPHARMA HOLDINGS IN (ASBP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.57).
The outstanding short interest for ASPIRE BIOPHARMA HOLDINGS IN (ASBP) is 0.32% of its float. Check the ownership tab for more information on the ASBP short interest.
Over the last trailing twelve months ASBP reported a non-GAAP Earnings per Share(EPS) of -1.57. The EPS decreased by -1194.69% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -182.56% | ||
ROE | -1998.64% | ||
Debt/Equity | 8.54 |